Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 13 di 13
Titolo Autore(i) Anno Periodico Editore Tipo File
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. A. MANSUKHANI; D. AMBROSETTI; G. HOLMES; L. CORNIVELLI; C. BASILICO. 2005-01-01 THE JOURNAL OF CELL BIOLOGY - 1.01 Articolo in rivista -
Cell-specific expression of the epm1 (cystatin B) gene in developing rat cerebellum. Riccio M;Santi S;Dembic M;Di Giaimo R;Cipollini E;Costantino-Ceccarini E;Ambrosetti D;Maraldi NM;...Melli M 2005-01-01 NEUROBIOLOGY OF DISEASE - 1.01 Articolo in rivista -
Mechanisms underlying differential responses to FGF signaling. L. Dailey ; D. Ambrosetti; A. Mansukhani; C. Basilico 2005-01-01 CYTOKINE & GROWTH FACTOR REVIEWS - 1.01 Articolo in rivista -
Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts Ambrosetti D; Holmes G; Mansukhani A; Basilico C. 2008-01-01 MOLECULAR AND CELLULAR BIOLOGY - 1.01 Articolo in rivista -
Tollip Is a Mediator of Protein Sumoylation A. Ciarrocchi; R. D'Angelo; C. Cordiglieri; A. Rispoli; S. Santi; M. Riccio; S. Carone; A. L. Man...cia; S. Paci; E. Cipollini; D. Ambrosetti; M. Melli 2009-01-01 PLOS ONE - 1.01 Articolo in rivista -
The transcription factor Sox2 is required for osteoblast self-renewal. U. Basu-Roy; Ambrosetti D.; Favaro R.; Nicolis S.K.; Mansukhani A.; Basilico C. 2010-01-01 CELL DEATH AND DIFFERENTIATION - 1.01 Articolo in rivista -
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2. Valentina, Sancisi; Greta, Gandolfi; Davide, Ambrosetti; Alessia, Ciarrocchi 2015-01-01 CANCER RESEARCH - 1.01 Articolo in rivista -
The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells Gobbi G.; Donati B.; Do Valle I.F.; Reggiani F.; Torricelli F.; Remondini D.; Castellani G.; Ambr...osetti D.C.; Ciarrocchi A.; Sancisi V. 2019-01-01 ONCOGENE - 1.01 Articolo in rivista -
Genome-scale CRISPR/Cas9 screening identifies Hippo pathway as key determinant for susceptibility to BET inhibitors in lung cancer Gobbi, G; Donati, B; Do Valle, IF; Reggiani, F; Torricelli, F; Remondini, D; Castellani, G; Ambro...setti, DC; Ciarrocchi, A; Sancisi, V 2020-01-01 MOLECULAR CANCER RESEARCH - 1.01 Articolo in rivista -
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapy Reggiani F.; Gobbi G.; Ciarrocchi A.; Ambrosetti D.C.; Sancisi V. 2020-01-01 BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER - 1.01 Articolo in rivista -
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma Reggiani F.; Sauta E.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Damia G....; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V. 2021-01-01 MOLECULAR CANCER - 1.01 Articolo in rivista s12943-021-01357-z.pdf
Csnk1a1, kdm2a, and ltb4r2 are new druggable vulnerabilities in lung cancer Sauta E.; Reggiani F.; Torricelli F.; Zanetti E.; Tagliavini E.; Santandrea G.; Gobbi G.; Strocch...i S.; Paci M.; Damia G.; Bellazzi R.; Ambrosetti D.; Ciarrocchi A.; Sancisi V. 2021-01-01 CANCERS - 1.01 Articolo in rivista cancers-13-03477.pdf
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling Gobbi G.; Grieco A.; Torricelli F.; Sauta E.; Santandrea G.; Zanetti E.; Fantini V.; Reggiani F.;... Strocchi S.; Paci M.; Vohra M.; Saladi S.V.; Ambrosetti D.C.; Ciarrocchi A.; Sancisi V. 2023-01-01 CELL DEATH & DISEASE - 1.01 Articolo in rivista -
Mostrati risultati da 1 a 13 di 13
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile